{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:51:09Z","timestamp":1790268669898,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jfma.2018.05.001","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T22:10:18Z","timestamp":1526595018000},"page":"260-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"P2","title":["The application of p2PSA% and prostate health index in prostate cancer detection: A\u00a0prospective cohort in a Tertiary Medical Center"],"prefix":"10.1016","volume":"118","author":[{"given":"Yung-Ting","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hung","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2859-3966","authenticated-orcid":false,"given":"Yeong-Shiau","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chuang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5989-6559","authenticated-orcid":false,"given":"Yi-Kai","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Chiang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-How","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ming","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7660-4412","authenticated-orcid":false,"given":"Shih-Chun","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.jfma.2018.05.001_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1365-2605.2000.00012.x","article-title":"Prostate cancer in Taiwan: epidemiology and risk factors","volume":"23","author":"Pu","year":"2000","journal-title":"Int J Androl"},{"key":"10.1016\/j.jfma.2018.05.001_bib2","series-title":"Cancer incidence and mortality rates in Taiwan","author":"TC","year":"2013"},{"key":"10.1016\/j.jfma.2018.05.001_bib3","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.1016\/S1470-2045(14)70211-6","article-title":"Prevention and early detection of prostate cancer","volume":"15","author":"Cuzick","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jfma.2018.05.001_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.294.1.66","article-title":"Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng\/ml or lower","volume":"294","author":"Thompson","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2018.05.001_bib5","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter","volume":"350","author":"Thompson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2018.05.001_bib6","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.6004\/jnccn.2015.0183","article-title":"The case for tailored prostate cancer screening: an NCCN perspective","volume":"13","author":"McDonald","year":"2015","journal-title":"J Natl Compr Canc Netw JNCCN"},{"key":"10.1016\/j.jfma.2018.05.001_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2302\/kjm.52.86","article-title":"Pro PSA: a more cancer specific form of prostate specific antigen for the early detection of prostate cancer","volume":"52","author":"Mikolajczyk","year":"2003","journal-title":"Keio J Med"},{"key":"10.1016\/j.jfma.2018.05.001_bib8","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1038\/srep05012","article-title":"Diagnostic ability of %p2PSA and prostate health index for aggressive prostate cancer: a meta-analysis","volume":"4","author":"Wang","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.jfma.2018.05.001_bib9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0929-6646(09)60394-6","article-title":"Diagnostic value of finger-guided prostate nodule biopsy combined with systemic random biopsy","volume":"108","author":"Chiang","year":"2009","journal-title":"J Formos Med Assoc Taiwan yi zhi."},{"key":"10.1016\/j.jfma.2018.05.001_bib10","first-page":"444","article-title":"Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with \"gray\u201d prostate-specific antigen levels at first biopsy: systematic review and meta-analysis","volume":"164","author":"Bruzzese","year":"2014","journal-title":"Transl Res J Lab Clin Med"},{"key":"10.1016\/j.jfma.2018.05.001_bib11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00345-012-0927-9","article-title":"Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0\u201310.0 ng\/mL range","volume":"31","author":"Ito","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.jfma.2018.05.001_bib12","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11255-013-0582-0","article-title":"The prostate health index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4\u201310 ng\/mL","volume":"46","author":"Ng","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.jfma.2018.05.001_bib13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4103\/1008-682X.168687","article-title":"Prospective validation of %p2PSA and the prostate health index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4\u201310 ng ml-1","volume":"19","author":"Tan","year":"2017","journal-title":"Asian J Androl"},{"key":"10.1016\/j.jfma.2018.05.001_bib14","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/pros.22876","article-title":"Performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and the prostate health index (PHI) in a Chinese hospital-based biopsy population","volume":"74","author":"Na","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.jfma.2018.05.001_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.juro.2011.09.060","article-title":"Distribution and associations of [-2]proenzyme-prostate specific antigen in community dwelling black and white men","volume":"187","author":"Rhodes","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.jfma.2018.05.001_bib16","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.eururo.2013.12.005","article-title":"Multicenter European external validation of a prostate health index-based nomogram for predicting prostate cancer at extended biopsy","volume":"66","author":"Lughezzani","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.jfma.2018.05.001_bib17","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.eururo.2013.01.011","article-title":"Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng\/ml: a multicentric European study","volume":"63","author":"Lazzeri","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.jfma.2018.05.001_bib18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/sj.pcan.4500957","article-title":"Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels","volume":"10","author":"Tanaka","year":"2007","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.jfma.2018.05.001_bib19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.urology.2011.09.056","article-title":"Longitudinal changes of benign prostate-specific antigen and [-2]pro-prostate-specific antigen over 7 years in a community-based sample of men","volume":"79","author":"Rhodes","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.jfma.2018.05.001_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.urolonc.2004.07.017","article-title":"Evaluation of precursor prostate-specific antigen isoform ratios in the detection of prostate cancer","volume":"23","author":"Naya","year":"2005","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jfma.2018.05.001_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000356240","article-title":"Evaluation of prostate-specific antigen isoform p2PSA and its derivates, %p2PSA, prostate health index and prostate dimension-adjusted related index in the detection of prostate cancer at first biopsy: an exploratory, prospective study","volume":"93","author":"Mearini","year":"2014","journal-title":"Urol Int"},{"key":"10.1016\/j.jfma.2018.05.001_bib22","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/bju.13762","article-title":"Prostate Health Index density improves detection of clinically significant prostate cancer","volume":"120","author":"Tosoian","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.jfma.2018.05.001_bib23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.juro.2007.09.083","article-title":"Prostate volume estimation using the ellipsoid formula consistently underestimates actual gland size","volume":"179","author":"Rodriguez","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.jfma.2018.05.001_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1370\/afm.2205","article-title":"Digital rectal examination for prostate cancer screening in primary care: a systematic review and meta-analysis","volume":"16","author":"Naji","year":"2018","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.jfma.2018.05.001_bib25","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0022-5347(01)61785-3","article-title":"Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng\/ml. or less","volume":"161","author":"Carvalhal","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.jfma.2018.05.001_bib26","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0022-5347(05)67711-7","article-title":"Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men","volume":"163","author":"Djavan","year":"2000","journal-title":"J Urol"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664618300688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664618300688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:38:34Z","timestamp":1760539114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664618300688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0929664618300688"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2018.05.001","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The application of p2PSA% and prostate health index in prostate cancer detection: A\u00a0prospective cohort in a Tertiary Medical Center","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2018.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}